David E. Kram

2.0k total citations · 1 hit paper
36 papers, 1.1k citations indexed

About

David E. Kram is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, David E. Kram has authored 36 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 15 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in David E. Kram's work include DNA Repair Mechanisms (13 papers), Carcinogens and Genotoxicity Assessment (12 papers) and DNA and Nucleic Acid Chemistry (8 papers). David E. Kram is often cited by papers focused on DNA Repair Mechanisms (13 papers), Carcinogens and Genotoxicity Assessment (12 papers) and DNA and Nucleic Acid Chemistry (8 papers). David E. Kram collaborates with scholars based in United States, Australia and Canada. David E. Kram's co-authors include Edward L. Schneider, Raymond R. Tice, Ernest Falke, Sheldon Wolff, A.V. Carrano, James W. Allen, Rhona Schreck, Samuel A. Latt, Stephen E. Bloom and G Bynum and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.

In The Last Decade

David E. Kram

33 papers receiving 999 citations

Hit Papers

Sister-chromatid exchanges: A report of the GENE-TOX program 1981 2026 1996 2011 1981 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David E. Kram United States 16 615 477 256 183 88 36 1.1k
B.E. Matter Switzerland 16 494 0.8× 347 0.7× 206 0.8× 209 1.1× 45 0.5× 38 966
Hamiyet Dönmez‐Altuntaş Türkiye 19 312 0.5× 386 0.8× 129 0.5× 123 0.7× 76 0.9× 70 975
Xueqing Liu China 23 230 0.4× 508 1.1× 160 0.6× 57 0.3× 74 0.8× 81 1.4k
Karen L. Pennington United States 19 126 0.2× 430 0.9× 221 0.9× 50 0.3× 170 1.9× 59 1.1k
Rachel M. Patterson United States 12 170 0.3× 365 0.8× 183 0.7× 32 0.2× 142 1.6× 26 751
Stefan Eriksson Sweden 9 254 0.4× 353 0.7× 124 0.5× 124 0.7× 51 0.6× 11 715
Hamid Vaghef Sweden 12 340 0.6× 224 0.5× 181 0.7× 97 0.5× 25 0.3× 14 613
Peng Lv China 15 106 0.2× 357 0.7× 99 0.4× 70 0.4× 69 0.8× 30 958
Silvina B. Nadin Argentina 12 167 0.3× 410 0.9× 63 0.2× 82 0.4× 95 1.1× 18 764

Countries citing papers authored by David E. Kram

Since Specialization
Citations

This map shows the geographic impact of David E. Kram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Kram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Kram more than expected).

Fields of papers citing papers by David E. Kram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Kram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Kram. The network helps show where David E. Kram may publish in the future.

Co-authorship network of co-authors of David E. Kram

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Kram. A scholar is included among the top collaborators of David E. Kram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Kram. David E. Kram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bell, Noah, Stephen T. Keir, Dominique Higgins, et al.. (2025). Repurposing the DNA Labeling Agent EdU for Therapy against Heterogeneous Patient Glioblastoma. Molecular Cancer Therapeutics. 24(8). 1213–1225. 1 indexed citations
2.
Kram, David E., et al.. (2025). Opportunities and challenges for patient-derived models of brain tumors in functional precision medicine. npj Precision Oncology. 9(1). 47–47. 7 indexed citations
3.
Kram, David E., et al.. (2025). Informing development of brain cancer therapies within "preclinical trials" using ex vivo patient tumors. Advanced Drug Delivery Reviews. 228. 115736–115736.
4.
Kram, David E., et al.. (2025). Therapeutic approaches for targeting the pediatric brain tumor microenvironment. Drug Delivery and Translational Research. 15(10). 3363–3389.
5.
Das, Anirban, Daniel A. Morgenstern, Sumedha Sudhaman, et al.. (2022). Immune Checkpoint Inhibition as Single Therapy for Synchronous Cancers Exhibiting Hypermutation: An IRRDC Study. JCO Precision Oncology. 6(6). e2100286–e2100286. 9 indexed citations
6.
Marlowe, Elizabeth M., et al.. (2022). Pilot study to determine effect of an altruism intervention focusing on herd immunity to enhance influenza vaccination rates. Vaccine. 40(46). 6625–6630. 2 indexed citations
7.
Kram, David E., et al.. (2018). Embryonal Tumors of the Central Nervous System in Children: The Era of Targeted Therapeutics. Bioengineering. 5(4). 78–78. 25 indexed citations
8.
Ramkissoon, Lori, Nicholas Britt, Eric A. Severson, et al.. (2018). Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas. Current Treatment Options in Oncology. 19(8). 41–41. 7 indexed citations
9.
Kram, David E., Stephanie M. Krasnow, Peter R. Levasseur, et al.. (2016). Dexamethasone Chemotherapy Does Not Disrupt Orexin Signaling. PLoS ONE. 11(12). e0168731–e0168731. 7 indexed citations
10.
Kram, David E., Carole Brathwaite, & Ziad Khatib. (2010). Bilateral conjunctival extranodal marginal zone B‐cell lymphoma. Pediatric Blood & Cancer. 55(7). 1414–1416. 6 indexed citations
12.
Latt, Samuel A., James W. Allen, Stephen E. Bloom, et al.. (1981). Sister-chromatid exchanges: A report of the GENE-TOX program. Mutation Research/Reviews in Genetic Toxicology. 87(1). 17–62. 487 indexed citations breakdown →
13.
Dean, R., G Bynum, David E. Kram, & Edward L. Schneider. (1980). Sister-chromatid exchange induction by carcinogens in HTC cells An in vitro system which does not require addition of activating factors. Mutation Research/Environmental Mutagenesis and Related Subjects. 74(6). 477–483. 19 indexed citations
14.
Tice, Raymond R., et al.. (1979). Cytokinetic analysis of the impaired proliferative response of peripheral lymphocytes from aged humans to phytohemagglutinin.. The Journal of Experimental Medicine. 149(5). 1029–1041. 92 indexed citations
15.
Kram, David E., et al.. (1979). Spontaneous and mitomycin-C induced sister-chromatid exchanges. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 60(3). 339–347. 25 indexed citations
16.
Kram, David E., et al.. (1979). In utero sister chromatid exchange analysis for detection of transplacental mutagens. Nature. 279(5713). 531–531. 33 indexed citations
17.
Kram, David E., Edward L. Schneider, Leon Singer, & George R. Martin. (1978). The effects of high and low fluoride diets on the frequencies of sister chromatid exchanges. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 57(2). 51–55. 35 indexed citations
18.
Kram, David E., Edward L. Schneider, Leon Singer, & George R. Martin. (1978). The effects of high and low fluoride diets on the frequencies of sister chromatid exchanges. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 57(1). 51–55. 48 indexed citations
19.
Kram, David E., et al.. (1978). Reduced frequencies of Mitomycin-C induced sister chromatid exchanges in AKR Mice. Human Genetics. 41(1). 20 indexed citations
20.
Kram, David E. & Norman W. Klein. (1976). Serum protein synthesis in the early chick embryo. Developmental Biology. 52(2). 300–309. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026